Supplementary Figure S2 from A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or Without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer
crossref(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined